NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)
National Institutes of Health · Department of Health and Human Services
At a glance
NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional) is a forecasted federal grant opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of June 1, 2027; forecast dates can change. Total estimated funding is $28M across about 30 awards. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Jul 2, 2026Forecast posted
- Apr 30, 2027 (est.)Full notice expectednext date
- Jun 1, 2027 (est.)Application deadline
- Mar 31, 2028 (est.)Est. award date
- Posted
- Jul 2, 2026
- Est. close date
- Jun 1, 2027
- Est. award date
- Mar 31, 2028
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- $28,000,000
- Implied average award
- $933,333 calculated
- Expected awards
- 30
- Cost sharing
- Not required
- Funding instrument
- Grant
- Opportunity category
- Discretionary
- Fiscal year
- FY2028
Typical awards for this program (SAM.gov listing for ALN 93.847, not this notice): Project Grants: Range of $1,300 to $10,834,000; $418,000 average NRSAs: Range of $2,500 to $869,000; $116,000 average SBIR: Range of $6,500 to $2,074,000; $585,000 average
Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Others (see notice)
Additional information on eligibility (from the notice)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
This Notice of Funding Opportunity (NOFO) invites applications for NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional). These Core Centers are part of an integrated program of biomedical and translational research supporting our cystic fibrosis, diabetes, nutrition, obesity, liver and digestive diseases research. They enhance multidisciplinary collaboration, rigor, reproducibility, replication and research cost efficiencies at institutions that already have a large established research base in one of the above focused areas within NIDDK’s mission. They should also provide a rich mentoring environment for trainees and early-stage investigators. The P30 Centers accomplish their purpose by providing a Pilot and Feasibility Grant Program, a Scientific Catalyst Program, and importantly shared access to the services of Cores. Within a given P30 Center, the Scientific Catalyst Program, which works within the Administrative Core, supports activities that strengthen the Center’s scientific community and advance its research mission. Activities may include research team building, investigator mentoring, seminars, workshops, visiting scientists, and scientific research series. The program is intended to foster multidisciplinary collaboration, attract new investigators, and engage investigators with expertise relevant to the Center’s chronic disease research focus. The Core Services reflect the research needs of the Center and may include research consultation along with services involving cell or other models, planning, analysis, hands-on services, access to expensive specialized equipment, other technical resources or training shared by the Center members and operated or overseen by recognized experts.
How to apply
0 of 8 done · progress saved in this browser
Assistance Listing
What is an ALN?Reported obligations under ALN 93.847
Historical data · not a predictionAgency contact (as published)
NIDDKP30s@NIH.gov
NIDDKP30s@NIH.gov
NIDDKP30s@NIH.gov
Quick answers
Is “NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)” open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around April 30, 2027. Forecast details and dates can change.
Who is eligible to apply for “NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)”?
The official notice lists these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.
How much funding is available through “NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)”?
Per the notice, total estimated program funding is $28,000,000 and the agency expects to make about 30 awards.
How do I apply for “NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)”?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-DK-28-112), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Single Source for Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Data Coordinating Center (DCC)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jul 1, 2026 (est.)
- Who can apply
- State governments, County governments, Public colleges & universities and 9 more
Single Source: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium- Renal and Environmental Science Core (U01-Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jul 1, 2026 (est.)
- Who can apply
- State governments, County governments, Special district governments and 9 more
Limited Competition: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium- Field Epidemiology Sites
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jul 1, 2026 (est.)
- Who can apply
- State governments, County governments, Public colleges & universities and 7 more
George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jul 1, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Oct 1, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 11 more
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health- Award range
- Up to $1M
- Closes
- Oct 9, 2026
- Who can apply
- State governments, County governments, City or township governments and 12 more